Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
ALUR-WT
#4094
Allurion Technologies, Inc.
0.016
0
-46.31%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-46.31%
Monatliche Änderung
-20.00%
6 month change
-40.74%
Jahresänderung
-58.44%
Vorheriger Schlusskurs
0.029
8
Open
0.017
0
Bid
Ask
Low
0.016
0
High
0.017
0
Volumen
5
Märkte
Aktien
ALUR-WT
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2023
2024
TTM
Key stats
Total common shares outstanding
1.91 M
5.96 M
—
Valuation ratios
Enterprise value
—
—
—
Price to earnings ratio
-0.01
-0
-0.01
Price to sales ratio
0.01
0
0.02
Price to cash flow ratio
0.01
0
0.01
Price to book ratio
0.01
0
0
Enterprise value to EBITDA ratio
—
—
—
Profitability ratios
Return on assets %
1.12
0.8
1.39
Return on equity %
1.14
0.34
0.49
Return on invested capital %
587.6
608.85
1 907.28
Gross margin %
77.61
66.97
242.83
Operating margin %
147.9
156.33
1 004.77
EBITDA margin %
-144.24
-148.99
-977.44
Net margin %
150.76
81.43
982.49
Liquidity ratios
Quick ratio
0.9
1.26
5.77
Current ratio
0.99
1.44
6.8
Inventory turnover
0.23
0.47
0.44
Asset turnover
0.75
0.61
0.51
Solvency ratios
Debt to assets ratio
—
—
—
Debt to equity ratio
—
—
—
Long term debt to total assets ratio
0.54
1.09
4.69
Long term debt to total equity ratio
0.55
0.46
1.74
Per share metrics
Operating cash flow per share
44.97
18.82
9.38
EBIT per share
-55.56
-22.34
-11.02
EBITDA per share
-54.19
-21.29
-10.82
Total debt per share
—
—
—
Cash per share
26.73
6.84
12.77
Net current asset value per share
45.54
12.08
22.69
Tangible book value per share
49.52
34.7
65.74
Working capital per share
-0.43
3.69
8.57
Book value per share
49.52
34.7
65.74
Nachrichten
Are Medical Stocks Lagging Allurion Technologies, Inc. (ALUR) This Year?
What's Going On With Allurion Stock On Wednesday? - Allurion Technologies (NYSE:ALUR)
Allurion-Aktie: Hochstufung auf „Buy“ nach FDA-Zulassung
Allurion Technologies stock rating upgraded on FDA approval
FDA-Zulassung für Magenballon: Allurion-Aktie schießt um 40 % in die Höhe
FDA approves Allurion gastric balloon for obesity treatment
Allurion stock surges 40% on U.S. FDA approval
Tracking Saudi Sovereign Wealth Fund’s 13F Portfolio – Q3 2025 Update
Allurion Technologies (ALUR) director sells $4.9k in shares
Allurion reports 23% weight loss combining balloon with low-dose GLP-1
Allurion Smart Capsule shows 20% weight reduction in new study
Zacks Industry Outlook Highlights Boston Scientific, Insulet, BioLife Solutions and Allurion